Qualigen Therapeutics (FRA:7R90) Days Inventory : 0.00 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Qualigen Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Qualigen Therapeutics's Average Total Inventories for the three months ended in Sep. 2024 was €0.00 Mil. Qualigen Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.00 Mil.

The historical rank and industry rank for Qualigen Therapeutics's Days Inventory or its related term are showing as below:

During the past 4 years, Qualigen Therapeutics's highest Days Inventory was 72.28. The lowest was 60.56. And the median was 66.42.

FRA:7R90's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 188.02
* Ranked among companies with meaningful Days Inventory only.

Qualigen Therapeutics's Days Inventory stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Qualigen Therapeutics Days Inventory Historical Data

The historical data trend for Qualigen Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qualigen Therapeutics Days Inventory Chart

Qualigen Therapeutics Annual Data

Trend

Mar20

Dec21

Dec22

Dec23

Days Inventory

60.53

72.90

Qualigen Therapeutics Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Qualigen Therapeutics's Days Inventory

For the Biotechnology subindustry, Qualigen Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qualigen Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qualigen Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Qualigen Therapeutics's Days Inventory falls into.

Qualigen Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Qualigen Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.497	+	0)	/	1 )	/	0	*	365
=	1.497					/	0	*	365
=	N/A

Qualigen Therapeutics's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:

	Days Inventory (Q: Sep. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2024 )	+	Total Inventories (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Qualigen Therapeutics (FRA:7R90) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Qualigen Therapeutics's Inventory Turnover for the three months ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Qualigen Therapeutics's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Qualigen Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Qualigen Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Qualigen Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qualigen Therapeutics Inc (FRA:7R90) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

QLGN:USA 7R90:Germany

Address

5857 Owens Avenue, Suite 300, Carlsbad, CA, USA, 92008

Website

https://www.qlgntx.com

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

Qualigen Therapeutics Headlines

No Headlines